Belvedere Trading LLC Cardiol Therapeutics Inc. Transaction History

Belvedere Trading LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 21, 2022	SELL	$1.03 - $2.05 $16,490 - $32,820	-16,010 Closed	0 $0
Q1 2022 Apr 20, 2022	SELL	$1.25 - $2.31 $13,777 - $25,460	-11,022 Reduced 40.77%	16,010 $29,000
Q4 2021 Jan 25, 2022	BUY	$1.83 - $4.86 $49,468 - $131,375	27,032 New	27,032 $49,000

5.07M

5.2K

9.5K

Ticker CRDL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 61,942,500
Market Cap $79.3M
Description
Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product is CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate t...

Get notified when there are updates to the investment portfolio of Belvedere Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Belvedere Trading LLC with notifications on news.